Animal Parasiticides Market Size, Share, Price, Trends, Growth,...

Animal Parasiticides Market Size, Share, Price, Trends, Growth, Report And Forecast 2022-2032

Posted 2025-07-16 11:47:22

The global animal parasiticides market, valued at US$ 7.9 billion in 2022, is projected to reach US$ 13.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.6%. The market is driven by increasing awareness of animal health, rising livestock populations, and technological advancements in parasiticide formulations.

Ectoparasiticides dominate with a 52% market share in 2022, while the companion animals segment is expected to grow at a CAGR of 6.1%, fueled by rising pet ownership and zoonotic disease concerns. Key trends include innovations in biotechnology, such as Merck’s SPHEREON technology, and increased investments in animal healthcare. Challenges include high product costs and limited R&D funding, particularly in developing regions, which may hinder market growth.

For More Insights into the Market, Request a Sample of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4316

Market Analysis

The animal parasiticides market is propelled by the need to prevent and manage parasitic infections in livestock and companion animals, driven by rising incidences of foodborne and zoonotic diseases. The market’s growth from US$ 6.2 billion in 2021 to a projected US$ 13.5 billion by 2032, at a 6.6% CAGR, reflects increased demand for livestock protection and advancements in veterinary healthcare. Ectoparasiticides, addressing external parasites like ticks and fleas, lead due to their critical role in preventing disease transmission. The companion animals segment, valued at US$ 1.8 billion in 2021, is growing rapidly due to rising pet ownership (67% of U.S. households per APPA) and heightened focus on pet welfare. However, high costs of parasiticides and substantial R&D investments pose challenges, particularly in less developed regions with limited awareness and funding.

Segment Analysis

The market is segmented by product type, species, and region. Ectoparasiticides, including oral tablets, sprays, and spot-on solutions, held a 52% share in 2021 and are expected to grow at a 6.3% CAGR, driven by the prevalence of external parasites. Endoparasiticides (e.g., injectable, oral suspensions) and endectocides also contribute significantly, addressing internal parasites. The companion animals segment, particularly dogs and felines, is the fastest-growing at a 6.1% CAGR, fueled by increasing pet healthcare needs. Food-producing animals, including cattle and poultry, remain vital due to demand for high-quality meat and dairy. North America leads with a 6.5% CAGR, holding three-tenths of the market, while Asia-Pacific, with a 6.2% CAGR, is expected to reach US$ 3.1 billion by 2026, driven by rising pet adoption and livestock production.

Country-wise Insights

The United States, projected to reach US$ 1.5 billion by 2032, dominates due to high pet ownership, increased demand for animal byproducts, and stringent regulations by the USDA’s Animal and Plant Health Inspection Service (APHIS) and Center for Veterinary Biologics (CVB). India, valued at US$ 265 million in 2021, is a key growth market in Asia-Pacific, driven by rising domesticated animal populations and demand for quality meat. Europe benefits from significant funding, such as the EU’s US$ 2.2 billion budget (2014–2020) for animal care, with 65% allocated to parasiticide-related measures. The Asia-Pacific region, particularly India and China, is expanding due to growing awareness of animal healthcare and investments in veterinary products.

Key Players

Zoetis, Inc.
Merck Animal Health
Ceva Sante Animale
Boehringer Ingelheim GmbH
Elanco Animal Health
Bayer AG
Bimeda Animal Health
Vetoquinol
Virbac
The Chanelle Group

Strategic Outlook and Industry Trends

The animal parasiticides market is evolving with innovations like Zoetis’s acquisition of NewMetrica in 2022 for digital tools assessing animal welfare and Ceva Sante Animale’s partnership with Mitsui to expand in Japan. Start-ups like Itch and Invetx are introducing tailored flea treatments and protein-based therapies, respectively, while Eupraxia Pharmaceuticals develops sustained-release drug delivery systems. Major players are focusing on R&D, direct sales, and strategic partnerships to enhance market share. The increasing prevalence of zoonotic diseases and demand for animal-based proteins are driving growth, but high costs and limited rural awareness remain challenges. Regulatory support and biotechnology advancements will continue to shape the market’s trajectory.

Browse Full Report on: https://www.factmr.com/report/4316/animal-parasiticides-market

Segmentation of Animal Parasiticides Market

By Product Type